SG Americas Securities, LLC - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 135 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SG Americas Securities, LLC ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$2,333
+268.6%
50,727
+200.7%
0.03%
+285.7%
Q1 2023$633
+113.1%
16,870
+59.3%
0.01%
+75.0%
Q4 2022$297
-99.8%
10,588
+138.8%
0.00%
+100.0%
Q3 2022$125,000
-68.4%
4,434
-61.0%
0.00%
-50.0%
Q2 2022$396,000
-3.2%
11,382
-0.2%
0.00%
+33.3%
Q1 2022$409,000
-51.1%
11,401
-68.3%
0.00%
-40.0%
Q4 2021$837,000
-44.7%
35,947
-54.8%
0.01%
-28.6%
Q3 2021$1,513,000
+1398.0%
79,603
+1350.8%
0.01%
+600.0%
Q1 2021$101,000
-93.6%
5,487
-93.5%
0.00%
-90.0%
Q3 2020$1,572,000
+678.2%
83,818
+514.5%
0.01%
+400.0%
Q1 2020$202,000
+48.5%
13,640
+94.1%
0.00%
+100.0%
Q4 2019$136,000
-64.9%
7,028
-62.9%
0.00%
-75.0%
Q1 2019$387,000
+140.4%
18,933
+133.4%
0.00%
+300.0%
Q4 2018$161,0000.0%8,112
-23.1%
0.00%0.0%
Q2 2018$161,000
-45.1%
10,544
-35.6%
0.00%
-66.7%
Q3 2017$293,000
+164.0%
16,385
+164.7%
0.00%
+200.0%
Q2 2017$111,000
-73.9%
6,190
-73.2%
0.00%
-75.0%
Q4 2016$426,00023,1020.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q1 2019
NameSharesValueWeighting ↓
Alambic Investment Management, L.P. 29,423$583,0000.44%
Matarin Capital Management, LLC 223,184$4,426,0000.34%
Summit Global Investments 42,725$847,0000.10%
FEDERATED HERMES, INC. 1,747,921$34,661,0000.08%
ROTHSCHILD & CO ASSET MANAGEMENT US INC. 347,307$6,887,0000.08%
MARSHALL WACE, LLP 413,293$8,196,0000.06%
BOSTON ADVISORS LLC 42,365$840,0000.04%
MARTINGALE ASSET MANAGEMENT L P 214,444$4,254,0000.04%
JACOBS LEVY EQUITY MANAGEMENT, INC 177,321$3,516,0000.04%
SILVERCREST ASSET MANAGEMENT GROUP LLC 231,041$4,582,0000.04%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders